Avandia Restrictions Hit Glaxosmithkline Q3 Profit

Pharmaceutical company GlaxoSmithKline reported a 3.5 percent drop in third-quarter earnings Thursday due to generic competition and a European ban on its diabetes drug Avandia, which was also restricted in the United States.

Topics:  glaxosmithkline   european   avandia   united   states   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News